Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

BACKGROUND: The glucose-lowering independent effect of sodium glucose cotransporter-2 inhibitors (SGLT2i) on arterial wall function has not yet been clarified. This study aims to assess whether SGLT2i treatment can attenuate endothelial dysfunction related to type 2 diabetes mellitus (T2D) compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Sposito, Andrei C., Breder, Ikaro, Soares, Alexandre A. S., Kimura-Medorima, Sheila T., Munhoz, Daniel B., Cintra, Riobaldo M. R., Bonilha, Isabella, Oliveira, Daniela C., Breder, Jessica Cunha, Cavalcante, Pamela, Moreira, Camila, Moura, Filipe A., de Lima-Junior, Jose Carlos, do Carmo, Helison R. P., Barreto, Joaquim, Nadruz, Wilson, Carvalho, Luiz Sergio F., Quinaglia, Thiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004411/
https://www.ncbi.nlm.nih.gov/pubmed/33771149
http://dx.doi.org/10.1186/s12933-021-01264-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004411/
https://www.ncbi.nlm.nih.gov/pubmed/33771149
http://dx.doi.org/10.1186/s12933-021-01264-z

Ejemplares similares